The company claims that by using its remote monitoring Tele-Health Suite, CHF home patients answer a range of health related questions. This is supplemented with medical parameters including blood pressure and weight. Data analysis is performed automatically and then sent and reviewed by a healthcare professional.

According to the study by the Department of Community and Family Medicine, School of Public Health, Faculty of Medicine, and Chinese University of Hong Kong, the coronary heart disease (CHD) is the second leading cause of cardiovascular deaths in China.

CHD accounts for 22% of cardiovascular deaths in urban areas and 13% in rural areas. Although mortality from CHD in China is relatively low compared to Western levels, the burden of CHD has been increasing. This is partly because of a worsening profile of risk factors, such as an increased prevalence of hypertension, hyperlipidaemia, overweight/obesity, diabetes, and partly because of an increase in the aged population.

Ning Wu, president of MDCE, said: “We are pleased to have completed this updated CHF application for our Tele-Health Suite. Research has demonstrated that on average, patients managing their CHF via telehealth remote monitoring can reduce their health care system utilization by up to 30%. This translates into substantial savings for both the patient and the healthcare system.”